AMTB is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near its pivot with weak momentum, no strong proprietary buy signal, and sentiment is mixed to negative. A long-term buyer would be better off waiting for clearer earnings improvement and stronger technical confirmation rather than buying immediately.
Current price is 22.43, essentially flat on the day and below recent resistance at 22.95. MACD histogram is negative and worsening, which points to weak momentum. RSI at 42.57 is neutral but not oversold, so there is no strong rebound signal. Moving averages are converging, showing consolidation rather than a clear uptrend. Support is near 21.53 and 21.09, while resistance sits at 22.95 and 23.39. The stock trend model suggests modest upside over time, but the current setup does not show a strong immediate entry.

["Analyst price target was raised to $24 from $23.", "Stock trend model indicates potential upside over the next week and month.", "Open interest put-call ratio of 0.5 suggests more bullish than bearish positioning."]
["Earnings estimate was revised down by nearly 13.7% over the past 60 days.", "AMTB was added to the Zacks Rank #5 Strong Sell list.", "Hedge funds are selling, with selling activity increasing 1633.98% last quarter.", "MACD is negative and worsening, indicating weak near-term momentum.", "No AI Stock Picker or SwingMax buy signal is present today."]
No financial snapshot was available due to an error, so latest-quarter revenue and earnings trends cannot be directly assessed. Based on the available news, the latest quarterly outlook appears weaker because earnings estimates have been cut significantly over the past 60 days, which suggests deteriorating forward expectations for the current season.
Keefe Bruyette raised the price target to $24 from $23 and kept a Market Perform rating on 2026-04-28. That is a modest positive adjustment, but the overall Wall Street view is still neutral rather than bullish. Pros: slightly higher target, some upside to current price. Cons: Market Perform implies limited conviction, and the broader analyst/news tone is negative given the recent downgrade in earnings expectations and Strong Sell classification.